Main content

Here are the first two stories related to the main content

Follow-up material to accompany the main content

Here are additional stories besides the main content

Coronavirus Swiss commodities sector grapples with Covid-19 turbulence

The importance of commodities and experience in handling fluctuations has helped commodity firms weather the coronavirus storm better than most.

Covid-19 Pandemic rattles already vulnerable antibiotics market

As money is poured into the search for a silver bullet to Covid-19, some experts warn that the pandemic could also worsen the antibiotics crisis.

Covid-19 Roche working ‘around the clock’ to provide coronavirus test

​​​​​​​ After getting the green light to deploy its coronavirus diagnostic test, Roche says it is working around the clock to make it available.

Covid-19 With no prospects for profits, big pharma neglects new infectious diseases

More companies are shifting resources away from emerging infectious diseases into more lucrative areas like cancer. What does this mean for Covid-19?

Coronavirus impact Chinese economic disruption hits Swiss supply chains

China’s sharp contraction in economic activity over the past month due to the coronavirus epidemic is sending shockwaves across the globe.

This content was published on March 4, 2020 6:00 PM

parliamentary decision Companies allowed to deduct fines abroad from taxes

Parliament has agreed that companies should be able to deduct fines imposed abroad from taxes breaking with federal government recommendations.

This content was published on March 2, 2020 7:29 PM